CY1491A - Pharmaceutical mixture - Google Patents

Pharmaceutical mixture

Info

Publication number
CY1491A
CY1491A CY1491A CY149182A CY1491A CY 1491 A CY1491 A CY 1491A CY 1491 A CY1491 A CY 1491A CY 149182 A CY149182 A CY 149182A CY 1491 A CY1491 A CY 1491A
Authority
CY
Cyprus
Prior art keywords
pharmaceutical mixture
pharmaceutical
mixture
Prior art date
Application number
CY1491A
Other languages
English (en)
Inventor
Rolf Ivar Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of CY1491A publication Critical patent/CY1491A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY1491A 1981-06-18 1982-06-10 Pharmaceutical mixture CY1491A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8103843A SE8103843L (sv) 1981-06-18 1981-06-18 Farmaceutisk mixtur

Publications (1)

Publication Number Publication Date
CY1491A true CY1491A (en) 1990-02-16

Family

ID=20344097

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1491A CY1491A (en) 1981-06-18 1982-06-10 Pharmaceutical mixture

Country Status (18)

Country Link
US (1) US4656027A (xx)
EP (1) EP0069097B1 (xx)
JP (1) JPS584714A (xx)
KR (1) KR880001752B1 (xx)
AR (1) AR231801A1 (xx)
AT (1) ATE22007T1 (xx)
CA (1) CA1208559A (xx)
CY (1) CY1491A (xx)
DE (1) DE3273153D1 (xx)
ES (1) ES513202A0 (xx)
FI (1) FI80589C (xx)
HK (1) HK62689A (xx)
IL (1) IL65859A (xx)
IS (1) IS1307B6 (xx)
MY (1) MY8700297A (xx)
PH (1) PH19626A (xx)
SE (1) SE8103843L (xx)
SG (1) SG36389G (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
NL8400911A (nl) * 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
DE69104453T2 (de) * 1990-09-13 1995-03-16 Akzo Nv Stabilisierte feste chemische Zusammensetzungen.
WO1993007858A1 (en) * 1991-10-16 1993-04-29 Arto Olavi Urtti Peroral drug delivery system
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
KR950703947A (ko) * 1992-11-06 1995-11-17 미즈노 시게루 고형 의약용 조성물의 제조방법(method of manufacturing composition for solid medicine)
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
AU4988696A (en) * 1995-03-29 1996-10-16 Procter & Gamble Company, The Antitussive microcapsules
JP3470198B2 (ja) * 1995-05-02 2003-11-25 大正製薬株式会社 経口投与用組成物
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
DE19706979A1 (de) * 1997-02-21 1998-08-27 Lindopharm Gmbh Kombinationspräparat für oral applizierbare Erythromycine
GB9928343D0 (en) * 1999-11-30 2000-01-26 Vericore Ltd Addition of tetracyclines to animal foodstuffs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
WO2001080826A2 (en) 2000-04-20 2001-11-01 Bristol-Myers Squibb Company Taste masking coating composition
CA2457100A1 (en) * 2001-08-01 2003-02-13 Bristol-Myers Squibb Company Taste masking composition
WO2003077842A2 (en) 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
JP3821081B2 (ja) * 2002-09-30 2006-09-13 日本電気株式会社 燃料電池およびこれを搭載した携帯機器ならびに燃料電池の運転方法
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
KR100503949B1 (ko) * 2003-04-28 2005-07-26 주식회사유한양행 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물
NZ553645A (en) * 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
CN101005830B (zh) * 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂、其制备方法及用途
JP2008525420A (ja) * 2004-12-23 2008-07-17 マクニール−ピーピーシー・インコーポレーテツド 感覚的きっかけ剤を有する、口で崩壊する薬用組成物
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
JP2009526021A (ja) * 2006-02-10 2009-07-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 放出を加減した製剤
WO2011040195A1 (ja) * 2009-09-30 2011-04-07 ライオン株式会社 不快味マスキング粒子及びこれを含有する経口製剤
WO2016136745A1 (ja) 2015-02-25 2016-09-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 キノリン誘導体の苦味抑制方法
CN108845065B (zh) * 2018-06-19 2021-06-22 广西壮族自治区食品药品检验所 测定磺胺嘧啶混悬液中有关物质的hplc法
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
AU2022253899A1 (en) 2021-04-07 2023-10-26 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL280827A (xx) * 1962-07-11 1900-01-01
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
JPS4843419B1 (xx) * 1970-08-07 1973-12-18
JPS541767B2 (xx) * 1973-03-09 1979-01-29
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
US4205060A (en) * 1978-12-20 1980-05-27 Pennwalt Corporation Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
JPS5587715A (en) * 1978-12-26 1980-07-02 Yoshitomi Pharmaceut Ind Ltd Stabilization of bacanpicillin hydrochloride
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Also Published As

Publication number Publication date
KR840000228A (ko) 1984-02-18
MY8700297A (en) 1987-12-31
SG36389G (en) 1989-10-13
EP0069097A3 (en) 1983-08-10
KR880001752B1 (ko) 1988-09-12
PH19626A (en) 1986-06-04
JPS584714A (ja) 1983-01-11
EP0069097B1 (en) 1986-09-10
DE3273153D1 (en) 1986-10-16
ATE22007T1 (de) 1986-09-15
FI822191L (fi) 1982-12-19
US4656027A (en) 1987-04-07
IS1307B6 (is) 1988-03-22
EP0069097A2 (en) 1983-01-05
FI822191A0 (fi) 1982-06-17
IL65859A (en) 1986-12-31
JPH0460968B2 (xx) 1992-09-29
FI80589B (fi) 1990-03-30
IL65859A0 (en) 1982-08-31
SE8103843L (sv) 1982-12-19
ES8308211A1 (es) 1983-08-16
FI80589C (fi) 1990-07-10
AR231801A1 (es) 1985-03-29
HK62689A (en) 1989-08-11
IS2730A7 (is) 1982-12-19
ES513202A0 (es) 1983-08-16
CA1208559A (en) 1986-07-29

Similar Documents

Publication Publication Date Title
DE3273153D1 (en) Pharmaceutical mixture
PH25637A (en) Dipyridamole-containing pharmaceutical form
ZA828797B (en) Pharmaceutical formulation
ZA834074B (en) Pharmaceutical composition
ZA824622B (en) Pharmaceutical compositions
PH21911A (en) Pharmaceutical mixture
EP0093551A3 (en) Pharmaceutical composition
ZA825397B (en) Pharmaceutical compositions
ZA822856B (en) Pharmaceutical compositions
ZA82652B (en) Pharmaceutical compositions
GB8332269D0 (en) Pharmaceutical compounds
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
GB8328896D0 (en) Pharmaceutical composition
SG59387G (en) Pharmaceutical compositions
ZW18582A1 (en) Pharmaceutical compositions
ZA822120B (en) Pharmaceutical preparation
GB8332653D0 (en) Pharmaceutical composition
ZA82186B (en) Pharmaceutical compositions
GB8320429D0 (en) Pharmaceutical preparation
GB8320438D0 (en) Pharmaceutical preparation
GB8314540D0 (en) Pharmaceutical composition
GB8319733D0 (en) Pharmaceutical mixture
GB8321269D0 (en) Pharmaceutical mixture
IE810190L (en) Pharmaceutical preparation containing¹poly-glycidyl-substituted n-heterocyclics
IE812410L (en) Pharmaceutical compositions